Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors

Investigational New Drugs
Shewei GuoGuosheng Zhou

Abstract

Microtubule as an important target in the cancer therapy was used to design novel tubulin polymerization inhibitors. Sulfanilamide-1,2,3-triazole hybrids were designed by a molecular hybridization strategy and their antiproliferative activity against three selected cancer cell lines (BGC-823, MGC-803 and SGC-7901) were evaluated. All sulfanilamide-1,2,3-triazole hybrids displayed potent inhibitory activity against all cell lines. In particular, compound 10b showed the most excellent inhibitory effect against MGC-803 cells, with an IC50 value of 0.4 μM. Cellular mechanism studies elucidated that 10b induced apoptosis by decreasing the expression level of Bcl-2 and Parp and increasing the expression level of BAX. 10b inhibited the epithelial-mesenchymal transition process by up-regulating E-cadherin and down-regulating N-cadherin. Furthermore, the tubulin polymerization inhibitory activity in vitro of 10b was 2.4 μM. In vivo anticancer assay, 10b effectively inhibited MGC-803 xenograft tumor growth without causing significant loss of body weight. These sulfanilamide-1,2,3-triazole hybrids as potent tubulin polymerization inhibitors might be used as promising candidates for cancer therapy.

References

Nov 11, 2011·European Journal of Medicinal Chemistry·Pardeep SinghA K Saxena
Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Dec 3, 2014·European Journal of Medicinal Chemistry·Małgorzata JeleńMaja Kocięba
Jan 23, 2016·Chemical Reviews·Vinod K TiwariXi Chen
Mar 15, 2016·European Journal of Medicinal Chemistry·Bruno M F GonçalvesMarta Cascante
Jul 18, 2016·Bioorganic & Medicinal Chemistry Letters·Dong-Jun FuYan-Bing Zhang
Jun 27, 2017·European Journal of Medicinal Chemistry·Sravanthi Devi GuggilapuNagendra Babu Bathini
Jul 18, 2017·Nature Communications·Akane Inoue-YamauchiEmily H Cheng
Sep 2, 2017·European Journal of Medicinal Chemistry·Giuseppe Felice MangiatordiOrazio Nicolotti
Sep 6, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dong-Jun FuYan-Bing Zhang
Dec 22, 2017·European Journal of Medicinal Chemistry·Hong-Yan LinYong-Hua Yang

❮ Previous
Next ❯

Citations

Mar 27, 2020·International Journal of Molecular Sciences·Krzysztof SzafrańskiAnna Kawiak

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.